Certara (CERT) Stock Price
Certara Price
Certara (CERT) Stock | ISIN US15687V1098 | WKN A2QJL8. The current Certara stock price is 5.22 USD (2026). Revenue is 453.55 M USD. Net income is 88.44 M USD. The P/E ratio is 9.47. Market capitalization is 831.39 M USD. Certara operates in the Health sector.
Certara stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Certara over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Certara stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Certara's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Certara Price |
|---|
Certara Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Certara Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Certara generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Certara retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Certara's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Certara has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Certara's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Certara stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Certara Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Certara business model & stock analysis
Certara SWOT Analysis
Strengths
Certara Inc has a strong reputation in the pharmaceutical industry due to its advanced technology and expertise in pharmacokinetic modeling and simulation.
The company offers a comprehensive range of software solutions and consulting services, which enables it to provide tailored solutions to pharmaceutical companies.
Certara Inc has a well-established customer base, including top pharmaceutical companies and regulatory agencies, which provides a stable source of revenue.
Weaknesses
Certara Inc relies heavily on the pharmaceutical industry, which is subject to market fluctuations and regulatory changes. These factors can impact the company's financial performance.
The company faces intense competition from other technology and consulting firms in the pharmaceutical industry, which could potentially affect its market share.
Opportunities
As pharmaceutical companies continue to focus on drug development and regulatory approval, there is an increasing demand for Certara's services and software solutions.
The incorporation of artificial intelligence and machine learning in pharmacokinetic modeling presents an opportunity for Certara Inc to further enhance its offerings and gain a competitive edge.
Threats
Changes in government regulations and industry standards can pose a threat to Certara Inc's business operations and may require the company to adapt its services accordingly.
The emergence of new competitors in the pharmaceutical technology and consulting space could potentially erode Certara Inc's market share and impact its revenue growth.
Certara Eulerpool Fair Value
Certara historical P/E ratio, EBIT multiple, and P/S ratio
Certara annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Certara shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Certara Earnings Estimates
Certara Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/11/2026 | 0.11USD | 108.22 MUSD | 2026 Q1 |
| 2/26/2026 | 0.11USD | 105.26 MUSD | 2025 Q4 |
| 11/6/2024 | 0.12USD | 93.35 MUSD | 2024 Q3 |
| 5/6/2024 | 0.12USD | 90.97 MUSD | 2024 Q1 |
| 2/28/2024 | 0.11USD | 88.34 MUSD | 2023 Q4 |
| 8/7/2023 | 0.13USD | 94.53 MUSD | 2023 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Certara stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Certara shareholder structure
| % | Name |
|---|---|
22.82026% | |
10.9238% | |
7.7888% | |
7.7216% | |
5.2441% | |
4.95349% | |
3.83933% | |
3.55591% | |
3.08419% | |
2.46506% |
Certara Executives and Management Board
Dr. William Feehery
(55)Chief Executive Officer, Director · since 2019
Mr. John Gallagher
(52)Chief Financial Officer, Senior Vice President
Mr. Leif Pedersen
(61)President, Chief Commercial Officer
Dr. Robert Aspbury
(53)President - Certara Predictive Technologies
Mr. James Cashman
(71)Independent Chairman of the Board
Frequently asked questions about Certara
The main competitors of Certara Inc in the market include industry leaders such as Simulations Plus, Inc. and Schrödinger, Inc.
Certara stock
Certara Peer Group
Certara Ticker
Certara FIGI
All fundamentals and in-depth analysis of Certara
Our stock analysis for Certara Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Certara Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.